Table 2.
Rates of detection of EYA4 and hTERT mRNA in peripheral blood mononuclear cells of the study subjects
| Control subjects (n = 50) |
BCH (n = 50) |
ESCD (n = 50) |
ESCC (n = 50) |
|
|---|---|---|---|---|
| EYA4 | ||||
| ≥ 0.2, n(%) | 7(14.0) | 10(20.0) | 13(26.0) | 26(52.0) |
| < 0.2, n(%) | 43(86.0) | 40(80.0) | 37(74.0) | 24(48.0) |
| hTERT | ||||
| ≥ 0.8, n(%) | 12(24.0) | 15(30.0) | 26(52.0) | 40(80.0) |
| < 0.8, n(%) | 38(76.0) | 35(70.0) | 24(48.0) | 10(20.0) |
×:χ2 = 19.643, P < 0.001, and linear-by-linear association = 16.246, P < 0.001 for EYA4 mRNA expression in the four groups; χ2 = 69.149, P < 0.001 and linear-by-linear association = 41.994, P < 0.001 for hTERT mRNA expression in the four groups. BCH, Basal cell hyperplasia; ESCD, esophageal squamous cells dyspalsia; ESCC, esophageal squamous cells cancer.